Soparkar Peter

CIK 00017363151 companyREDWOOD CITY, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001736315

Recent Transactions

50 trades

Disposition from Tender
Adverum Biotechnologies, Inc.
Common Stock
2025-12-09−80,189→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−39,476→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−38,500→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−15,999→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−13,999→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−4,074→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−45,000→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−78,750→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−64,394→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−40,000→ 0 total
Disposition from Tender
Adverum Biotechnologies, Inc.
Common Stock - Performance Stock Units
2025-12-09−157,333→ 0 total
Award
Adverum Biotechnologies, Inc.
Common Stock - Performance Stock Units
2025-12-09+150,000→ 157,333 total
Disposition from Tender
Adverum Biotechnologies, Inc.
Common Stock - Restricted Stock Units
2025-12-09−13,125→ 0 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2025-12-05$4.22/sh+50,000→ 80,189 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17+13,000→ 13,000 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17−40,000→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17−13,000→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17−16,384→ 0 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17+40,000→ 40,000 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17−4,074→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17−13,999→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17−15,999→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17−25,500→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17−45,000→ 0 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17+15,999→ 15,999 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17+25,500→ 25,500 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17+23,092→ 23,092 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17+13,999→ 13,999 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17−23,092→ 0 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17+16,384→ 16,384 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17+4,074→ 4,074 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17+45,000→ 45,000 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2025-05-15$2.00/sh−2,960→ 39,154 total
Award
Adverum Biotechnologies, Inc.
Common Stock
2025-02-25+13,125→ 42,114 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-02-25+78,750→ 78,750 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2024-08-02+64,394→ 64,394 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2024-02-12+450,000→ 450,000 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2023-10-03+130,000→ 130,000 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2023-03-15$0.78/sh−13,360→ 265,891 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2023-03-01+400,000→ 400,000 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2022-09-19$1.07/sh−13,305→ 273,251 total
Award
Adverum Biotechnologies, Inc.
Performance Based Stock Option (Right to Buy)
2022-09-14+230,924→ 230,924 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2022-09-14+163,847→ 163,847 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2022-04-19$1.14/sh+21,750→ 280,556 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2022-04-19$1.14/sh+175→ 258,806 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2022-03-08+255,000→ 255,000 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2021-12-08$1.91/sh+25,000→ 258,631 total
Award
Adverum Biotechnologies, Inc.
Common Stock
2021-08-06+220,000→ 230,692 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2021-08-06+160,000→ 160,000 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2021-02-16+140,000→ 140,000 total

Companies

Adverum Biotechnologies, Inc.
CHIEF OPERATING OFFICER

Recent Filings

Address

C/O ADVERUM BIOTECHNOLOGIES, INC. 100 CARDINAL WAY

REDWOOD CITY, CA, 94063

View on SEC.gov